Back to Search
RANDALL BELT, D.O.
D.O.
Family Medicine Physician
NPI: 1265475321IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine Physician
Emergency Medicine
Code: 207P00000X
1640(TN)1756(WV)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
1640(TN)
Education
WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE
Class of 1998
Research & Publications (13)
Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation.
PMID 19379511·J Hematol Oncol·2009
8-other
Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial.
PMID 19150937·Ann Oncol·2009
3-trial
Acquired pure megakaryocytic aplasia: report of a single case treated with mycophenolate mofetil.
PMID 17301968·Am J Hematol·2007
5-case
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
PMID 17947727·J Clin Oncol·2007
3-trial
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.
PMID 16782917·J Clin Oncol·2006
3-trial
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
PMID 17075122·J Clin Oncol·2006
3-trial
Destructive facial T-cell lymphoma: the difficulty in diagnosis of pyoderma-like processes.
PMID 15985028·Int J Dermatol·2005
5-case
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.
PMID 15447994·Clin Cancer Res·2004
3-trial
Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study.
PMID 14556680·Clin Lymphoma·2003
3-trial
Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study.
PMID 12468337·Gynecol Oncol·2002
3-trial
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.
PMID 11773161·J Clin Oncol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1420 TUSCULUM BLVD
GREENEVILLE, TN 37745 - Phone
- (423) 787-5000
Quick Facts
- NPI
- 1265475321
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 28
- Publications
- 13
Are you this provider?
Claim Your Profile